🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 19 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/08/1985 | 3,10 | 3,11 | 3,09 | 3,10 | -0,22% | 0,43% | 3.546.432 |
| 22/08/1985 | 3,11 | 3,12 | 3,09 | 3,11 | -0,21% | 0,96% | 4.844.275 |
| 21/08/1985 | 3,08 | 3,11 | 3,07 | 3,11 | +1,07% | 1,29% | 6.134.573 |
| 20/08/1985 | 3,05 | 3,08 | 3,05 | 3,08 | +1,09% | 1,19% | 7.911.562 |
| 19/08/1985 | 3,04 | 3,06 | 3,04 | 3,05 | +0,22% | 0,65% | 2.863.555 |
| 16/08/1985 | 3,03 | 3,04 | 3,03 | 3,04 | +0,11% | 0,43% | 7.809.696 |
| 15/08/1985 | 3,02 | 3,05 | 3,02 | 3,04 | +0,55% | 0,88% | 7.006.090 |
| 14/08/1985 | 3,00 | 3,02 | 3,00 | 3,02 | +1,00% | 0,99% | 4.553.770 |
| 13/08/1985 | 2,98 | 3,00 | 2,98 | 2,99 | +0,56% | 0,89% | 3.029.558 |
| 12/08/1985 | 2,97 | 2,99 | 2,97 | 2,98 | +0,45% | 0,78% | 1.543.075 |
| 09/08/1985 | 2,98 | 2,98 | 2,96 | 2,96 | -0,44% | 0,44% | 6.206.256 |
| 08/08/1985 | 2,96 | 2,98 | 2,96 | 2,98 | +0,45% | 0,67% | 2.203.315 |
| 07/08/1985 | 2,95 | 2,96 | 2,95 | 2,96 | +0,56% | 0,56% | 4.051.987 |
| 06/08/1985 | 2,97 | 3,00 | 2,95 | 2,95 | -0,89% | 1,89% | 6.338.304 |
| 05/08/1985 | 2,96 | 2,98 | 2,95 | 2,97 | -0,11% | 0,78% | 4.029.350 |
| 02/08/1985 | 3,00 | 3,00 | 2,97 | 2,98 | -0,88% | 0,77% | 1.686.442 |
| 01/08/1985 | 3,00 | 3,01 | 2,99 | 3,00 | +0,33% | 0,44% | 3.331.382 |
| 31/07/1985 | 3,00 | 3,01 | 2,98 | 2,99 | +0,11% | 0,77% | 5.074.416 |
| 30/07/1985 | 2,97 | 2,99 | 2,97 | 2,99 | +0,22% | 0,89% | 3.908.621 |
| 29/07/1985 | 2,99 | 2,99 | 2,97 | 2,98 | -0,22% | 0,56% | 4.342.493 |
| 26/07/1985 | 3,02 | 3,02 | 2,99 | 2,99 | -1,31% | 1,32% | 8.096.429 |
| 25/07/1985 | 3,06 | 3,07 | 3,02 | 3,03 | -1,40% | 1,52% | 6.696.720 |
| 24/07/1985 | 3,08 | 3,09 | 3,06 | 3,07 | -0,64% | 0,97% | 5.749.747 |
| 23/07/1985 | 3,09 | 3,11 | 3,09 | 3,09 | +0,11% | 0,64% | 5.387.558 |
| 22/07/1985 | 3,09 | 3,09 | 3,08 | 3,09 | -0,43% | 0,43% | 4.202.899 |
| 19/07/1985 | 3,10 | 3,11 | 3,09 | 3,10 | +0,11% | 0,64% | 13.004.842 |
| 18/07/1985 | 3,09 | 3,11 | 3,09 | 3,10 | -0,22% | 0,64% | 4.353.811 |
| 17/07/1985 | 3,08 | 3,11 | 3,08 | 3,10 | +0,86% | 0,86% | 10.141.286 |
| 16/07/1985 | 3,07 | 3,08 | 3,06 | 3,08 | +0,43% | 0,54% | 6.538.262 |
| 15/07/1985 | 3,05 | 3,07 | 3,05 | 3,06 | +0,32% | 0,76% | 4.587.725 |